Results 51 to 60 of about 274,252 (355)
Genomic analysis of Neisseria elongata isolate from a patient with infective endocarditis
FEBS Open Bio, 2021 Neisseria elongata is part of the commensal microbiota of the oropharynx. Although it is not considered pathogenic to humans, N. elongata has been implicated in several cases of infective endocarditis (IE).
Marcos André Schörner +7 more
doaj +1 more source
SARS-CoV-2 serology testing: Progress and challenges
JIM - Journal of Immunological Methods, 2021 The coronavirus disease 2019 (COVID-19) pandemic has caused the most devasting social and economic impact of this century. The current pandemic will end only after a safe, effective vaccine becomes available and protective herd immunity has been achieved
Aria C. Shi, Ping Ren
semanticscholar +1 more source
A systematic review of maternal TORCH serology as a screen for suspected fetal infection
Prenatal Diagnosis, 2021 The acronym ‘TORCH’ refers to well‐recognised causes of perinatal infections: toxoplasmosis, rubella, cytomegalovirus (CMV) and herpes simplex virus (HSV). A TORCH serology panel is often used to test for maternal primary infection following detection of
D. Fitzpatrick, N. Holmes, L. Hui
semanticscholar +1 more source
British Journal of Dermatology, 2020 Acral lesions, mainly chilblains, are the most frequently reported cutaneous lesions associated with COVID‐19. In more than 80% of patients tested, nasopharyngeal swabs were negative on reverse transcription polymerase chain reaction (RT‐PCR) for SARS ...
L. L. Cleach +20 more
semanticscholar +1 more source
Fatal lymphoproliferation and acute monocytic leukemia-like disease following infectious mononucleosis in the elderly [PDF]
, 1981 Three elderly patients are reported, in whom serologically confirmed recent infectious mononucleosis is followed by fatal lymphoproliferation (case 1), by acute monocytic leukemia (case 2), and by acute probably monocytic leukemia (case 3)
Deinhardt, F. +5 more
core +1 more source
Commercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2
medRxiv, 2020 Background. Currently it is unknown whether a positive serology results correlates with protective immunity against SARS-CoV-2. There are also concerns regarding the low positive predictive value of SARS-CoV-2 serology tests, especially when testing ...
R. Suhandynata +9 more
semanticscholar +1 more source
COVID, 2021 This review explores and positions the value of serology testing to support current immunization policies and the broader policy response to the coronavirus disease 2019 (COVID-19) crisis in Europe.
P. Bonanni +7 more
semanticscholar +1 more source
Cysticercosis and taeniasis cases diagnosed at two referral medical institutions, Belgium, 1990 to 2015 [PDF]
, 2019 Background: Few case reports on human infections with the beef tapeworm Taenia saginata and the pork tapeworm, Taenia solium, diagnosed in Belgium have been published, yet the grey literature suggests a higher number of cases.
Bottieau, Emmanuel +6 more
core +1 more source
The COVID-19 Serology Studies Workshop: Recommendations and Challenges
Immunity, 2020 Summary The development, validation, and appropriate application of serological assays to detect antibodies to SARS-CoV-2 are essential to determining seroprevalence of this virus in the United States and globally and in guiding government leadership and
Andrea Lerner +6 more
semanticscholar +1 more source
Comprehensive, comparative evaluation of 25 automated SARS-CoV-2 serology assays
Microbiology SpectrumThe onset of the COVID-19 pandemic resulted in hundreds of in vitro devices coming to market, facilitated by regulatory authorities allowing “Emergency Use,” without a prior comprehensive evaluation of performance.
Wayne Dimech +2 more
doaj +1 more source